- Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)–Like Pigmentation in a Metastatic Breast Cancer Patient
-
Mariano M, Donati P, Cameli N, Pigliacelli F, Morrone A, Cristaudo A
- KMID: 2515173
- J Breast Cancer.
- 2021 Feb;24(1):117-121.
- doi: 10.4048/jbc.2021.24.e1
Ribociclib is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor that has been approved in combination with endocrine therapy for the treatment of hormone receptor-positive/ human epidermal growth factor 2-negative advanced... -
- CITED
-
- Close
- SHARE
-
- Close
